Delivery Order SPE2DB22D1017-SPE2DB24FF8CK

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $1,731.21 and an ultimate completion date of October 30, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), which is a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the federal government. The contract has a ceiling value of $12,946.27 and is a firm fixed price delivery order with an ultimate completion date of June 25, 2024. The contract is not set aside for any special...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $12,205.01. The contract is a Firm Fixed Price Delivery Order with a completion date of November 3, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,783.65 and an ultimate completion date of March 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $16,209.63, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of Eliquis 5 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $7,739.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract is a delivery order issued under Amerisourcebergen's...
The federal contract award summarized is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $17,691.29, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $27,704.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,379.45 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC has a total potential value of up to...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract has a ceiling value of $9,400.50 and an ultimate completion date of April 25, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company serving the federal government. The contract is a delivery order...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF8CK
    Delivery Order

This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distribution company, for a ceiling value of $12,438.63. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. The contract has a firm fixed price pricing type and a completion date of May 22, 2024.

Generated 8/20/24, 9:19 AM